Yorvipath (Palopegteriparatide)

**Product type:** Human Prescription Drug

**Active ingredient:** PALOPEGTERIPARATIDE

**Strength:** 420 ug/1.4mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Ascendis Pharma, Endocrinology, Inc.

**Marketing category:** NDA (NDA216490)

**Pharmacologic class:** Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]